Canaccord Genuity Starts TELA Bio, Inc. (TELA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Canaccord Genuity Starts TELA Bio, Inc. (TELA) at Buy
December 3, 2019 7:47 AM EST
JMP Securities analyst David Turklay initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Market Outperform rating and a price target of $22.00.
The analyst comments "Rarely does one see new medical solutions that provide significant benefits to essentially all constituents (i.e.,... More
December 3, 2019 4:32 AM EST
Piper Jaffray analyst Matt O/Briend initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Overweight rating and a price target of $17.00.
For an analyst ratings summary and ratings history on TELA Bio, Inc.... More
December 3, 2019 4:32 AM EST
Jefferies analyst Raj Denhoy initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Buy rating and a price target of $23.00.
For an analyst ratings summary and ratings history on TELA Bio, Inc.... More
